Effectiveness and safety of combined dupilumab and risankizumab in concomitant atopic dermatitis and psoriasis

Int J Dermatol. 2024 Dec 12. doi: 10.1111/ijd.17610. Online ahead of print.

Authors

Davide Termini^{1

2}, Gianluca Tavoletti^{1

2}, Alessandra Chiei-Gallo², Gianluca Avallone^{1

2}, Francesca L Boggio³, Angelo V Marzano^{1

2}, Silvia M Ferrucci¹

Affiliations

¹ Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
² Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
³ Pathology Unit, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy.

PMID: 39668419
DOI: 10.1111/ijd.17610

No abstract available

Keywords: atopic dermatitis; biologic drugs; dupilumab; psoriasis; risankizumab.

Publication types

Letter